Higher-Than-Replacement Testosterone Plus Finasteride Treatment After SCI

Trial Profile

Higher-Than-Replacement Testosterone Plus Finasteride Treatment After SCI

Recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Jul 2017

At a glance

  • Drugs Finasteride (Primary) ; Testosterone enanthate (Primary)
  • Indications Spinal cord injuries
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jul 2017 Planned primary completion date changed from 1 May 2019 to 31 May 2019.
    • 18 Jan 2017 Status changed from not yet recruiting to recruiting.
    • 07 Jul 2016 Planned initiation date changed from 1 May 2016 to 1 Aug 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top